Annual Total Liabilities
$866.34 M
+$245.44 M+39.53%
December 31, 2023
Summary
- As of February 7, 2025, RGEN annual total liabilities is $866.34 million, with the most recent change of +$245.44 million (+39.53%) on December 31, 2023.
- During the last 3 years, RGEN annual total liabilities has risen by +$492.60 million (+131.80%).
- RGEN annual total liabilities is now at all-time high.
Performance
RGEN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$813.96 M
-$61.60 M-7.04%
September 30, 2024
Summary
- As of February 7, 2025, RGEN quarterly total liabilities is $813.96 million, with the most recent change of -$61.60 million (-7.04%) on September 30, 2024.
- Over the past year, RGEN quarterly total liabilities has increased by +$288.39 million (+54.87%).
- RGEN quarterly total liabilities is now -7.36% below its all-time high of $878.67 million, reached on March 31, 2024.
Performance
RGEN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RGEN Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +39.5% | +54.9% |
3 y3 years | +131.8% | +54.7% |
5 y5 years | +444.7% | +144.0% |
RGEN Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +42.4% | -7.4% | +54.9% |
5 y | 5-year | at high | +154.6% | -7.4% | +141.7% |
alltime | all time | at high | >+9999.0% | -7.4% | >+9999.0% |
Repligen Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $813.96 M(-7.0%) |
Jun 2024 | - | $875.56 M(-0.4%) |
Mar 2024 | - | $878.67 M(+1.4%) |
Dec 2023 | $866.34 M(+39.5%) | $866.34 M(+64.8%) |
Sep 2023 | - | $525.57 M(-9.1%) |
Jun 2023 | - | $578.08 M(-3.3%) |
Mar 2023 | - | $597.74 M(-3.7%) |
Dec 2022 | $620.90 M(+2.1%) | $620.90 M(-1.0%) |
Sep 2022 | - | $627.42 M(-1.9%) |
Jun 2022 | - | $639.55 M(+3.6%) |
Mar 2022 | - | $617.42 M(+1.5%) |
Dec 2021 | $608.29 M(+62.8%) | $608.29 M(+15.6%) |
Sep 2021 | - | $526.13 M(+27.4%) |
Jun 2021 | - | $412.90 M(+11.3%) |
Mar 2021 | - | $371.11 M(-0.7%) |
Dec 2020 | $373.74 M(+9.8%) | $373.74 M(+6.3%) |
Sep 2020 | - | $351.45 M(+2.8%) |
Jun 2020 | - | $342.02 M(+1.6%) |
Mar 2020 | - | $336.72 M(-1.1%) |
Dec 2019 | $340.35 M(+114.0%) | $340.35 M(+2.0%) |
Sep 2019 | - | $333.59 M(+76.2%) |
Jun 2019 | - | $189.30 M(+9.5%) |
Mar 2019 | - | $172.90 M(+8.7%) |
Dec 2018 | $159.05 M(+4.7%) | $159.05 M(+2.2%) |
Sep 2018 | - | $155.64 M(+6.3%) |
Jun 2018 | - | $146.42 M(+0.2%) |
Mar 2018 | - | $146.06 M(-3.9%) |
Dec 2017 | $151.97 M(+26.5%) | $151.97 M(-3.4%) |
Sep 2017 | - | $157.37 M(+33.6%) |
Jun 2017 | - | $117.82 M(+3.5%) |
Mar 2017 | - | $113.84 M(-5.3%) |
Dec 2016 | $120.15 M(+411.5%) | $120.15 M(+1.4%) |
Sep 2016 | - | $118.53 M(-0.0%) |
Jun 2016 | - | $118.59 M(+543.2%) |
Mar 2016 | - | $18.44 M(-21.5%) |
Dec 2015 | $23.49 M(+41.8%) | $23.49 M(+27.6%) |
Sep 2015 | - | $18.40 M(-3.8%) |
Jun 2015 | - | $19.12 M(+14.8%) |
Mar 2015 | - | $16.65 M(+0.6%) |
Dec 2014 | $16.56 M(+12.2%) | $16.56 M(+16.2%) |
Sep 2014 | - | $14.25 M(+5.6%) |
Jun 2014 | - | $13.49 M(+28.7%) |
Mar 2014 | - | $10.48 M(-29.0%) |
Dec 2013 | $14.76 M(+14.5%) | $14.76 M(+28.6%) |
Sep 2013 | - | $11.48 M(-5.9%) |
Jun 2013 | - | $12.20 M(+23.2%) |
Mar 2013 | - | $9.90 M(-23.1%) |
Dec 2012 | $12.89 M(+28.0%) | $12.89 M(+15.1%) |
Sep 2012 | - | $11.19 M(-12.0%) |
Jun 2012 | - | $12.72 M(+8.5%) |
Mar 2012 | - | $11.72 M(+147.7%) |
Dec 2011 | $10.07 M(+93.4%) | - |
Sep 2011 | - | $4.73 M(+10.3%) |
Jun 2011 | - | $4.29 M(-17.6%) |
Mar 2011 | $5.21 M(-1.7%) | $5.21 M(+23.5%) |
Dec 2010 | - | $4.22 M(-3.4%) |
Sep 2010 | - | $4.37 M(+4.6%) |
Jun 2010 | - | $4.17 M(-21.3%) |
Mar 2010 | $5.30 M(+14.4%) | $5.30 M(+32.7%) |
Dec 2009 | - | $3.99 M(-2.3%) |
Sep 2009 | - | $4.08 M(+27.7%) |
Jun 2009 | - | $3.20 M(-31.0%) |
Mar 2009 | $4.63 M(-2.1%) | $4.63 M(+20.5%) |
Dec 2008 | - | $3.84 M(+18.7%) |
Sep 2008 | - | $3.24 M(+14.4%) |
Jun 2008 | - | $2.83 M(-40.2%) |
Mar 2008 | $4.73 M(+33.8%) | $4.73 M(+41.9%) |
Dec 2007 | - | $3.34 M(-16.2%) |
Sep 2007 | - | $3.98 M(+12.9%) |
Jun 2007 | - | $3.53 M(-0.4%) |
Mar 2007 | $3.54 M | $3.54 M(-1.2%) |
Dec 2006 | - | $3.58 M(+23.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2006 | - | $2.90 M(-0.9%) |
Jun 2006 | - | $2.93 M(-7.6%) |
Mar 2006 | $3.17 M(-4.6%) | $3.17 M(-6.0%) |
Dec 2005 | - | $3.37 M(+10.3%) |
Sep 2005 | - | $3.05 M(+22.7%) |
Jun 2005 | - | $2.49 M(-25.0%) |
Mar 2005 | $3.32 M(+35.4%) | $3.32 M(+21.8%) |
Dec 2004 | - | $2.72 M(+9.6%) |
Sep 2004 | - | $2.49 M(+2.0%) |
Jun 2004 | - | $2.44 M(-0.6%) |
Mar 2004 | $2.45 M(+9.2%) | $2.45 M(-12.7%) |
Dec 2003 | - | $2.81 M(+2.6%) |
Sep 2003 | - | $2.74 M(+15.3%) |
Jun 2003 | - | $2.37 M(+5.8%) |
Mar 2003 | $2.24 M(-15.9%) | $2.24 M(+31.9%) |
Dec 2002 | - | $1.70 M(-57.9%) |
Sep 2002 | - | $4.03 M(-16.2%) |
Jun 2002 | - | $4.82 M(+80.7%) |
Mar 2002 | $2.67 M(+112.2%) | $2.67 M(+98.1%) |
Dec 2001 | - | $1.35 M(-9.6%) |
Sep 2001 | - | $1.49 M(+32.6%) |
Jun 2001 | - | $1.12 M(-10.7%) |
Mar 2001 | $1.26 M(+5.0%) | $1.26 M(+9.3%) |
Dec 2000 | - | $1.15 M(+18.8%) |
Sep 2000 | - | $968.00 K(+23.2%) |
Jun 2000 | - | $786.00 K(-34.3%) |
Mar 2000 | $1.20 M(+91.8%) | $1.20 M(+139.4%) |
Dec 1999 | - | $500.00 K(0.0%) |
Sep 1999 | - | $500.00 K(-28.6%) |
Jun 1999 | - | $700.00 K(+12.1%) |
Mar 1999 | $624.30 K(+56.1%) | $624.30 K(+56.1%) |
Dec 1998 | - | $400.00 K(-20.0%) |
Sep 1998 | - | $500.00 K(0.0%) |
Jun 1998 | - | $500.00 K(+25.0%) |
Mar 1998 | $400.00 K(-42.9%) | $400.00 K(+33.3%) |
Dec 1997 | - | $300.00 K(0.0%) |
Sep 1997 | - | $300.00 K(-40.0%) |
Jun 1997 | - | $500.00 K(-28.6%) |
Mar 1997 | $700.00 K(-84.1%) | $700.00 K(-12.5%) |
Dec 1996 | - | $800.00 K(+33.3%) |
Sep 1996 | - | $600.00 K(-33.3%) |
Jun 1996 | - | $900.00 K(-79.5%) |
Mar 1996 | $4.40 M(-72.0%) | $4.40 M(-45.0%) |
Dec 1995 | - | $8.00 M(-16.7%) |
Sep 1995 | - | $9.60 M(+7.9%) |
Jun 1995 | - | $8.90 M(-43.3%) |
Mar 1995 | $15.70 M(+21.7%) | $15.70 M(+23.6%) |
Dec 1994 | - | $12.70 M(+13.4%) |
Sep 1994 | - | $11.20 M(-5.9%) |
Jun 1994 | - | $11.90 M(-7.8%) |
Mar 1994 | $12.90 M(-11.6%) | $12.90 M(+5.7%) |
Dec 1993 | - | $12.20 M(+9.9%) |
Sep 1993 | - | $11.10 M(-3.5%) |
Jun 1993 | - | $11.50 M(-21.2%) |
Mar 1993 | $14.60 M(+342.4%) | $14.60 M(+97.3%) |
Dec 1992 | - | $7.40 M(+8.8%) |
Sep 1992 | - | $6.80 M(+65.9%) |
Jun 1992 | - | $4.10 M(+24.2%) |
Mar 1992 | $3.30 M(0.0%) | $3.30 M(+17.9%) |
Dec 1991 | - | $2.80 M(+12.0%) |
Sep 1991 | - | $2.50 M(-10.7%) |
Jun 1991 | - | $2.80 M(-15.2%) |
Mar 1991 | $3.30 M(-2.9%) | $3.30 M(+26.9%) |
Dec 1990 | - | $2.60 M(+4.0%) |
Sep 1990 | - | $2.50 M(-10.7%) |
Jun 1990 | - | $2.80 M(-17.6%) |
Mar 1990 | $3.40 M(+21.4%) | $3.40 M(+21.4%) |
Mar 1989 | $2.80 M(+12.0%) | $2.80 M(+12.0%) |
Mar 1988 | $2.50 M(+38.9%) | $2.50 M(+38.9%) |
Mar 1987 | $1.80 M(-83.6%) | $1.80 M(-83.6%) |
Mar 1986 | $11.00 M(+6.8%) | $11.00 M(+6.8%) |
Mar 1985 | $10.30 M | $10.30 M |
FAQ
- What is Repligen annual total liabilities?
- What is the all time high annual total liabilities for Repligen?
- What is Repligen annual total liabilities year-on-year change?
- What is Repligen quarterly total liabilities?
- What is the all time high quarterly total liabilities for Repligen?
- What is Repligen quarterly total liabilities year-on-year change?
What is Repligen annual total liabilities?
The current annual total liabilities of RGEN is $866.34 M
What is the all time high annual total liabilities for Repligen?
Repligen all-time high annual total liabilities is $866.34 M
What is Repligen annual total liabilities year-on-year change?
Over the past year, RGEN annual total liabilities has changed by +$245.44 M (+39.53%)
What is Repligen quarterly total liabilities?
The current quarterly total liabilities of RGEN is $813.96 M
What is the all time high quarterly total liabilities for Repligen?
Repligen all-time high quarterly total liabilities is $878.67 M
What is Repligen quarterly total liabilities year-on-year change?
Over the past year, RGEN quarterly total liabilities has changed by +$288.39 M (+54.87%)